Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Chen YG, Tsaih SW, Serreze DV.

Genes Immun. 2012 Feb;13(2):164-74. doi: 10.1038/gene.2011.68. Epub 2011 Sep 22.

2.

Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions.

Tsaih SW, Khaja S, Ciecko AE, MacKinney E, Chen YG.

Genes Immun. 2013 Sep;14(6):380-6. doi: 10.1038/gene.2013.32. Epub 2013 May 30.

3.

Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc.

Dose M, Sleckman BP, Han J, Bredemeyer AL, Bendelac A, Gounari F.

Proc Natl Acad Sci U S A. 2009 May 26;106(21):8641-6. doi: 10.1073/pnas.0812255106. Epub 2009 May 7.

4.

Essential role for autophagy during invariant NKT cell development.

Salio M, Puleston DJ, Mathan TS, Shepherd D, Stranks AJ, Adamopoulou E, Veerapen N, Besra GS, Hollander GA, Simon AK, Cerundolo V.

Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):E5678-87. doi: 10.1073/pnas.1413935112. Epub 2014 Dec 15.

5.

Loss of microRNAs in thymus perturbs invariant NKT cell development and function.

Seo KH, Zhou L, Meng D, Xu J, Dong Z, Mi QS.

Cell Mol Immunol. 2010 Nov;7(6):447-53. doi: 10.1038/cmi.2010.49. Epub 2010 Sep 20.

6.

Invariant NKT cell development and function in microRNA-223 knockout mice.

Li K, Seo KH, Gao T, Zheng Q, Qi RQ, Wang H, Weiland M, Dong Z, Mi QS, Zhou L.

Int Immunopharmacol. 2011 May;11(5):561-8. doi: 10.1016/j.intimp.2010.11.004. Epub 2010 Nov 19.

PMID:
21094288
7.

Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model.

Macedo MF, Quinta R, Pereira CS, Sa Miranda MC.

Mol Genet Metab. 2012 May;106(1):83-91. doi: 10.1016/j.ymgme.2012.02.014. Epub 2012 Mar 1.

PMID:
22425450
8.

Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.

Porubsky S, Speak AO, Salio M, Jennemann R, Bonrouhi M, Zafarulla R, Singh Y, Dyson J, Luckow B, Lehuen A, Malle E, Müthing J, Platt FM, Cerundolo V, Gröne HJ.

J Immunol. 2012 Sep 15;189(6):3007-17. doi: 10.4049/jimmunol.1201483. Epub 2012 Aug 8.

9.

IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression.

Milpied P, Massot B, Renand A, Diem S, Herbelin A, Leite-de-Moraes M, Rubio MT, Hermine O.

Blood. 2011 Sep 15;118(11):2993-3002. doi: 10.1182/blood-2011-01-329268. Epub 2011 Jun 8.

10.

An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells.

White AJ, Jenkinson WE, Cowan JE, Parnell SM, Bacon A, Jones ND, Jenkinson EJ, Anderson G.

J Immunol. 2014 Mar 15;192(6):2659-66. doi: 10.4049/jimmunol.1303057. Epub 2014 Feb 7.

11.

Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus.

Drennan MB, Franki AS, Dewint P, Van Beneden K, Seeuws S, van de Pavert SA, Reilly EC, Verbruggen G, Lane TE, Mebius RE, Deforce D, Elewaut D.

J Immunol. 2009 Aug 15;183(4):2213-6. doi: 10.4049/jimmunol.0901213. Epub 2009 Jul 20.

12.

Developmental dynamics of post-selection thymic DN iNKT.

Yassai M, Cooley B, Gorski J.

PLoS One. 2012;7(8):e43509. doi: 10.1371/journal.pone.0043509. Epub 2012 Aug 22.

13.

miR-150 regulates the development of NK and iNKT cells.

Bezman NA, Chakraborty T, Bender T, Lanier LL.

J Exp Med. 2011 Dec 19;208(13):2717-31. doi: 10.1084/jem.20111386. Epub 2011 Nov 28.

14.

Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells.

Astrakhan A, Ochs HD, Rawlings DJ.

J Immunol. 2009 Jun 15;182(12):7370-80. doi: 10.4049/jimmunol.0804256.

15.

Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation.

Castillo EF, Acero LF, Stonier SW, Zhou D, Schluns KS.

Blood. 2010 Oct 7;116(14):2494-503. doi: 10.1182/blood-2010-03-277103. Epub 2010 Jun 25.

16.

TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.

Subleski JJ, Hall VL, Wolfe TB, Scarzello AJ, Weiss JM, Chan T, Hodge DL, Back TC, Ortaldo JR, Wiltrout RH.

J Immunol. 2011 Jan 15;186(2):838-47. doi: 10.4049/jimmunol.1001735. Epub 2010 Dec 10.

17.

An Optimized Method for Isolating and Expanding Invariant Natural Killer T Cells from Mouse Spleen.

Govindarajan S, Elewaut D, Drennan M.

J Vis Exp. 2015 Oct 29;(105):e53256. doi: 10.3791/53256.

18.

MHC class II-expressing thymocytes suppress invariant NKT cell development.

Li W, Sofi MH, Wei DG, Du W, Gervay-Hague J, Renukaradhya GJ, Brutkiewicz RR, Chang CH.

Immunol Cell Biol. 2009 Feb;87(2):186-9. doi: 10.1038/icb.2008.78. Epub 2008 Nov 4.

19.

Metabolic regulator Fnip1 is crucial for iNKT lymphocyte development.

Park H, Tsang M, Iritani BM, Bevan MJ.

Proc Natl Acad Sci U S A. 2014 May 13;111(19):7066-71. doi: 10.1073/pnas.1406473111. Epub 2014 Apr 30.

20.

Making memory at birth: understanding the differentiation of natural killer T cells.

Engel I, Kronenberg M.

Curr Opin Immunol. 2012 Apr;24(2):184-90. doi: 10.1016/j.coi.2012.01.012. Epub 2012 Feb 2. Review.

Supplemental Content

Support Center